Transforming growth factor-beta in human cutaneous leishmaniasis (Q35798613)

10 August 2017

title

Transforming growth factor-beta in human cutaneous leishmaniasis (English)

1 reference

10 August 2017

main subject

cutaneous leishmaniasis

1 reference

A Barral

1

1 reference

10 August 2017

M Teixeira

2

1 reference

10 August 2017

P Reis

3

1 reference

10 August 2017

V Vinhas

4

1 reference

10 August 2017

J Costa

5

1 reference

10 August 2017

H Lessa

6

1 reference

10 August 2017

A L Bittencourt

7

1 reference

10 August 2017

S Reed

8

1 reference

10 August 2017

E M Carvalho

9

1 reference

10 August 2017

M Barral-Netto

10

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

The American Journal of Pathology

10 August 2017

published in

1 reference

10 August 2017

volume

147

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

947-954

1 reference

Leishmania major interferes with antigen presentation by infected macrophages

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Transforming growth factor-beta in tegumentary leishmaniasis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Mucosal leishmaniasis ("espundia" Escomel, 1911).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Immunologic responsiveness in American cutaneous leishmaniasis lesions.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Tumor necrosis factor (cachectin) in human visceral leishmaniasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871026

Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects

25 September 2018

1 reference

12 December 2020

Selection of a skin test antigen for American visceral leishmaniasis

1 reference

12 December 2020

Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells

1 reference

12 December 2020

Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells

1 reference

12 December 2020

Deactivation of macrophages by transforming growth factor-β

1 reference

12 December 2020

Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis

1 reference

12 December 2020

Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma

1 reference

12 December 2020

Phagocytosis of Leishmania enhances macrophage activation by IFN-gamma and lipopolysaccharide

1 reference

12 December 2020

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

1 reference

12 December 2020

Cytotoxicity in human mucosal and cutaneous leishmaniasis

1 reference

12 December 2020

Identifiers

PMC publication ID

1871026

1 reference

10 August 2017

1 reference